Helix BioPharma Corp. (HBPCF)
HBPCF Stock Price Chart
Explore Helix BioPharma Corp. interactive price chart. Choose custom timeframes to analyze HBPCF price movements and trends.
HBPCF Company Profile
Discover essential business fundamentals and corporate details for Helix BioPharma Corp. (HBPCF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
27 Nov 2009
Employees
7.00
Website
https://www.helixbiopharma.comCEO
Jacek Antas
Description
Helix BioPharma Corp. operates as an immune-oncology company in Canada. The company is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. It has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.
HBPCF Financial Timeline
Browse a chronological timeline of Helix BioPharma Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Mar 2026
Upcoming earnings on 22 Oct 2025
Upcoming earnings on 2 Sept 2025
Earnings released on 16 Jun 2025
EPS came in at -$0.02 .
Earnings released on 14 Mar 2025
EPS came in at -$0.10 .
Earnings released on 16 Dec 2024
EPS came in at -$0.02 .
Earnings released on 24 Oct 2024
EPS came in at -$0.08 .
Stock split effective on 16 Aug 2024
Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 May 2024
EPS came in at -$0.01 .
Earnings released on 29 Apr 2024
EPS came in at -$0.00 .
Earnings released on 14 Dec 2023
EPS came in at -$0.05 .
Earnings released on 27 Oct 2023
EPS came in at -$0.05 .
Earnings released on 14 Jun 2023
EPS came in at -$0.05 .
Earnings released on 15 Mar 2023
EPS came in at -$0.05 .
Earnings released on 14 Dec 2022
EPS came in at -$0.05 .
Earnings released on 31 Oct 2022
EPS came in at -$0.01 .
Earnings released on 14 Jun 2022
EPS came in at -$0.05 .
Earnings released on 16 Mar 2022
EPS came in at -$0.05 .
Earnings released on 15 Dec 2021
EPS came in at -$0.05 .
Earnings released on 9 Dec 2021
EPS came in at -$0.10 .
Earnings released on 14 Jun 2021
EPS came in at -$0.10 .
Earnings released on 16 Mar 2021
EPS came in at -$0.10 .
Earnings released on 15 Dec 2020
EPS came in at -$0.10 .
Earnings released on 29 Oct 2020
EPS came in at -$0.02 matching the estimated -$0.02.
HBPCF Stock Performance
Access detailed HBPCF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.